AZLIN Drug Patent Profile
✉ Email this page to a colleague
When do Azlin patents expire, and what generic alternatives are available?
Azlin is a drug marketed by Bayer Pharms and is included in three NDAs.
The generic ingredient in AZLIN is azlocillin sodium. Additional details are available on the azlocillin sodium profile page.
Summary for AZLIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 43 |
Patent Applications: | 4,822 |
Formulation / Manufacturing: | see details |
DailyMed Link: | AZLIN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for AZLIN
US Patents and Regulatory Information for AZLIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bayer Pharms | AZLIN | azlocillin sodium | INJECTABLE;INJECTION | 062388-001 | Sep 8, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bayer Pharms | AZLIN | azlocillin sodium | INJECTABLE;INJECTION | 062388-003 | Sep 8, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bayer Pharms | AZLIN | azlocillin sodium | INJECTABLE;INJECTION | 062388-002 | Sep 8, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bayer Pharms | AZLIN | azlocillin sodium | INJECTABLE;INJECTION | 062417-003 | Oct 12, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bayer Pharms | AZLIN | azlocillin sodium | INJECTABLE;INJECTION | 062417-001 | Oct 12, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bayer Pharms | AZLIN | azlocillin sodium | INJECTABLE;INJECTION | 050562-001 | Sep 3, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bayer Pharms | AZLIN | azlocillin sodium | INJECTABLE;INJECTION | 050562-002 | Sep 3, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |